Achieve Life Sciences, Inc. Share Price & Technical Analysis
ACHV · $5.46 (-0.36%)
Healthcare / Biotechnology
$5.46
-0.36%
Achieve Life Sciences, Inc., a late-stage pharmaceutical company, develops and commercializes cytisinicline for nicotine independence in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a naturally occurring alkaloid that interacts with nicotine receptors in the brain that reduces the severity of nicotine withdrawal symptoms. It has license and supply agreements…
Price chart
Seasonality
Jun has 1 positive and 4 negative years (last 5 years shown)
8% return in Jun, -21% avg return in past 3 year Jun month.
31% return in 2026, 59% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -16% | 10% | -36% | 47% | 18% | 8% | – | – | – | – | – | – | 31% |
| 25 | -6% | -3% | -13% | -4% | 38% | -36% | 18% | 20% | 10% | 59% | -6% | 4% | 83% |
| 24 | 17% | -16% | 12% | -4% | 18% | -11% | 6% | -10% | 7% | 0% | -6% | -22% | -11% |
| 23 | 96% | 0% | 39% | 22% | -28% | -16% | 8% | -12% | -14% | -9% | 49% | -29% | 105% |
| 22 | -8% | 1% | 4% | -8% | -1% | -29% | 2% | -8% | -28% | -35% | 27% | -11% | -94% |
Monthly return % by calendar month · historical pattern, not a forecast
Neutral · Strong · Uptrend
Achieve Life Sciences, Inc., a late-stage pharmaceutical company, develops and commercializes cytisinicline for nicotine independence in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a naturally occurring alkaloid that interacts with nicotine receptors in the brain that reduces the severity of nicotine withdrawal symptoms. It has license and supply agreements with Sopharma AD and University of Bristol. Achieve Life Sciences, Inc., is headquartered in Bothell, Washington.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$557.95M
P/E ratio
—
52W high
$6.15
52W low
$2.00
Volume
2,94,481
Beta
2.26
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹35,920
Abbott Laboratories Cede…
₹33,540
Eli Lilly And Company Ce…
₹30,700
Unitedhealth Group Inc C…
₹18,590
₹7,059
Frequently asked questions
- What is Achieve Life Sciences, Inc. share price today?
- Achieve Life Sciences, Inc. (ACHV) last traded around $5.46 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does ACHV have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for ACHV. Download the app for real-time alerts.
- How can I analyze Achieve Life Sciences, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.